A Massachusetts extract producer has crafted a new product that it claims is far superior to the vast majority of others in the industry for various reasons.
On Tuesday, PHCO2 announced the launch of Aquazome, a water-soluble extract designed to be used for multiple applications including beverages, horse and pet supplies, edibles, capsules, tablets, CBD tinctures and lotions.
PHCO2 claims that Aquazome contains a 35 per cent concentration of CBD, yielding a far greater potency than several other products in the market that generally have about a 10-20 per cent ratio of the cannabinoid.
The company also says pharmacokinetics studies have shown that the product has an 80 per cent absorption rate while other competing technologies have merely a fraction of that.
Read more: Green Thumb set to launch ‘RISE Express’ pot shops in Florida next year
Read more: Hemp Inc. raises cultivar yielding high-grade protein in its leaves
Other allegedly superior characteristics of Aquazome include true water solubility compared to other extracts that are only water dispensable/dispersable and higher bioavailability.
The new product is GMP compliant and has been crafted with USDA-certified organic material in a kosher-certified facility, according to the company.
“We are thrilled, once again, to be on the forefront of the CBD industry as we take this leap ahead with another innovation. Water soluble CDB ingredients will allow customers higher bioavailability per serving and deeper efficacy,” said William Smart, business development manager for the company.
“We have over 30 years of experience producing a variety of botanical emulsions, and work closely with customers in the design and development of an emulsion for each application to help ensure comparability in each product.”
